Cargando…

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics

Recent reports on the effects of psychedelic-assisted therapies for mood disorders and addiction, as well as the effects of psychedelics in the treatment of cluster headache, have demonstrated promising therapeutic results. In addition, the beneficial effects appear to persist well after limited exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schindler, Emmanuelle A. D., Wallace, Ryan M., Sloshower, Jordan A., D’Souza, Deepak C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838010/ https://www.ncbi.nlm.nih.gov/pubmed/29545753 http://dx.doi.org/10.3389/fphar.2018.00177

Ejemplares similares

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
por: Markopoulos, Athanasios, et al.
Publicado: (2022)

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023)

Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis
por: Basedow, Lukas A., et al.
Publicado: (2021)

Psychedelic Medicine: Creating an Introductory Course for Mental Health Professionals and Trainees
por: Prueitt, William L., et al.
Publicado: (2022)

Serotonergic Psychedelics in Neural Plasticity
por: Lukasiewicz, Kacper, et al.
Publicado: (2021)

Serotonergic Psychedelics Temporarily Modify Information Transfer in Humans
por: Alonso, Joan Francesc, et al.
Publicado: (2015)

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
por: Galvão-Coelho, Nicole L., et al.
Publicado: (2021)

Bedside to bench: the outlook for psychedelic research
por: Acero, Victor P., et al.
Publicado: (2023)

Classic Psychedelics and Human–Animal Relations
por: Pöllänen, Elin, et al.
Publicado: (2022)

How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
por: Artin, Hewa, et al.
Publicado: (2021)

Predicting Responses to Psychedelics: A Prospective Study
por: Haijen, Eline C. H. M., et al.
Publicado: (2018)

Unifying Theories of Psychedelic Drug Effects
por: Swanson, Link R.
Publicado: (2018)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)

Case report: Psychedelic-induced seizures captured by intracranial electrocorticography
por: Blond, Benjamin N., et al.
Publicado: (2023)

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
por: Kettner, H., et al.
Publicado: (2021)

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

Amazonian Medicine and the Psychedelic Revival: Considering the “Dieta”
por: O’Shaughnessy, David M., et al.
Publicado: (2021)

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
por: Roseman, Leor, et al.
Publicado: (2022)

The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies
por: Shepherd, J. H., et al.
Publicado: (2023)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies
por: Borgland, Stephanie L., et al.
Publicado: (2022)

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
por: Vorobyeva, Nataliya, et al.
Publicado: (2022)

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
por: Breeksema, Joost J, et al.
Publicado: (2022)

Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics
por: Sexton, James D., et al.
Publicado: (2020)

Brain serotonergic circuitries
por: Charnay, Yves, et al.
Publicado: (2010)

The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders
por: Olivier, Jocelien D. A., et al.
Publicado: (2013)

Classic Psychedelic Drugs: Update on Biological Mechanisms
por: Vollenweider, Franz X., et al.
Publicado: (2022)

Classic psychedelics, health behavior, and physical health
por: Simonsson, Otto, et al.
Publicado: (2022)

Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders
por: Vorobyeva, Nataliya, et al.
Publicado: (2023)

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2019)

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
por: Schenberg, Eduardo Ekman
Publicado: (2018)

Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs
por: Tagliazucchi, Enzo
Publicado: (2022)

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2021)

Sustained effects of single doses of classical psychedelics in humans
por: Knudsen, Gitte M.
Publicado: (2022)

Associations between lifetime classic psychedelic use and markers of physical health
por: Simonsson, Otto, et al.
Publicado: (2021)

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe
por: Miliano, Cristina, et al.
Publicado: (2019)

The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology
por: Winkelman, Michael James
Publicado: (2021)

Associations between lifetime classic psychedelic use and cardiometabolic diseases
por: Simonsson, Otto, et al.
Publicado: (2021)

Classic psychedelics do not affect T cell and monocyte immune responses
por: Rudin, Deborah, et al.
Publicado: (2023)

The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies
por: Castelhano, João, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e2o6qtqr7a31tuchl0ir1l8tta